Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

September 15, 2009; 73 (11) Articles

Association of plasma amyloid β with risk of dementia

The prospective Three-City Study

J. -C. Lambert, S. Schraen-Maschke, F. Richard, N. Fievet, O. Rouaud, C. Berr, J. -F. Dartigues, C. Tzourio, A. Alpérovitch, L. Buée, P. Amouyel
First published September 14, 2009, DOI: https://doi.org/10.1212/WNL.0b013e3181b78448
J. -C. Lambert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Schraen-Maschke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Richard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Fievet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. Rouaud
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Berr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. -F. Dartigues
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Tzourio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Alpérovitch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Buée
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Amouyel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Association of plasma amyloid β with risk of dementia
The prospective Three-City Study
J. -C. Lambert, S. Schraen-Maschke, F. Richard, N. Fievet, O. Rouaud, C. Berr, J. -F. Dartigues, C. Tzourio, A. Alpérovitch, L. Buée, P. Amouyel
Neurology Sep 2009, 73 (11) 847-853; DOI: 10.1212/WNL.0b013e3181b78448

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
474

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective: Several lines of evidence indicate that a decrease in the CSF concentration of amyloid β42 (Aβ42) is a potential biomarker for incident Alzheimer disease. In contrast, studies on plasma Aβ1–40 and Aβ1–42 peptide levels have yielded contradictory results. Here, we explored the links between incident dementia and plasma Aβ1–40 and Aβ1–42 peptide concentrations in the prospective, population-based Three-City (3C) Study. We also assessed the association between plasma concentrations of truncated Aβ (Aβn-40 and Aβn-42) and the risk of dementia.

Methods: During a subsequent 4-year follow-up period, 257 individuals presented incident dementia from 8,414 participants, and a subcohort of 1,185 individuals without dementia was drawn as a control cohort. Plasma levels of Aβ1–40, Aβ1–42, Aβn-40, and Aβn-42 were measured using an xMAP-based assay technology. The association between plasma Aβ peptide levels and the risk of dementia was assessed using Cox proportional hazard models.

Results: Of the various Aβ variables analyzed, the Aβ1–42/Aβ1–40 and Aβn-42/Aβn-40 ratios presented the strongest association with the risk of dementia: people with a high Aβ1–42/Aβ1–40 or Aβn-42/Aβn-40 ratio had a lower risk of developing dementia. These associations were restricted to individuals diagnosed at 2 years of follow-up and the Aβn-42/Aβn-40 ratio was mainly associated with the risk of mixed/vascular dementia.

Conclusion: Plasma Aβ peptide concentrations and Aβ1–42/Aβ1–40 and Aβn-42/Aβn-40 ratios may be useful markers to indicate individuals susceptible to short-term risk of dementia.

Glossary

Aβ=
amyloid β;
AD=
Alzheimer disease;
BMI=
body mass index;
CI=
confidence interval;
DSM-IV=
Diagnostic and Statistical Manual of Mental Disorders, 4th edition;
HDL=
high-density lipoprotein;
HR=
hazard ratio;
INSERM=
Institut National de la Santé et de la Recherche Médicale;
MCI=
mild cognitive impairment;
3C=
Three-City.
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • METHODS
    • RESULTS
    • DISCUSSION
    • AUTHOR CONTRIBUTIONS
    • ACKNOWLEDGMENT
    • FINANCIAL SUPPORT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Topics Discussed

  • Alzheimer's disease
  • Cohort studies
  • Incidence studies
  • Vascular dementia

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise